CRSP/N fundamentals
An in-depth look to CRISPR THERAPEUTICS AG operating, investing, and financing activities
CRSP/N free cash flow for Q2 24 is -1.77 B MXN. For 2023, CRSP/N free cash flow was -4.58 B MXN and operating cash flow was -4.42 B MXN.
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
0.00
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: MXN
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
TTM